According to the US Department of Justice in the gel for ultrasound of Pharmaceutical Innovations Inc. from New Jersey were detected bacteria: Pseudomonas aeruginosa and Klebsiella oxytoca, the check was initiated after a few (16) cases of infection by Pseudomonas aeruginosa in Michigan Hospital during surgery to replace heart valves under the control of the transesophageal echocardiography (no deaths), as a result the manufacturer suffered a loss of 100 thousand dollars (50 thousand fine and 50 thousand - gel costs which must be destroyed), and sentenced to 2 years probation (providing free access of independent experts to the production line) and the destruction of the contaminated batch of gel for ultrasound.
